Table 2.

Positive rate of CHOP, caspase-12, NF-κB p65, and Bcl-2 expression levels in the liver cirrhosis group and the control group (mean ± SD)

Groups		CHOP	Caspase-12	NF-κB p65	Bcl-2
Control (n = 18)	Week 4	1.14 ± 0.14	1.12 ± 0.16	1.08 ± 0.18	4.60 ± 0.19
	Week 6	1.07 ± 0.26	1.20 ± 0.09	1.17 ± 0.11	5.21 ± 0.14
	Week 8	1.32 ± 0.19	1.07 ± 0.21	1.21 ± 0.13	4.91 ± 0.08
Liver cirrhosis (n = 24)	Week 4	2.17 ± 0.49	2.24 ± 0.49	6.44 ± 0.25*	8.82 ± 0.44*
	Week 6
	Week 8
Liver cirrhosis (n = 24)	Week 4	2.45 ± 0.66	3.91 ± 0.26	3.02 ± 0.19#	6.3 ± 0.36#
	Week 6
	Week 8
Liver cirrhosis (n = 24)	Week 4	8.83 ± 0.59*,#,Δ	9.80 ± 0.31*,#,Δ	2.62 ± 0.24#	3.75 ± 0.19#,Δ
	Week 6
	Week 8

^* P < 0.05 vs. corresponding control group at each time point;

^# P < 0.05 vs. 4-wk liver cirrhosis group;

^Δ P < 0.05 vs. 6-wk liver cirrhosis group.